is tirzepatide for type 2 diabetes (Mounjaro): Drug Guide VisualAbstract: Once-weekly tirzepatide significantly improves

And in 2022, I started Mounjaro (tirzepatide), which is FDA-approved for type 2 diabetes but used off-label for weight loss

Generally, benign thyroid conditions or a history of common thyroid cancers are not absolute contraindications for GLP-1 therapy

Further, whether this was through glucagon action on glucagon or GLP-1r was also studied

Book your GLP-1 consultation today at Restore Hyper Wellness in Delray Beach, FL

The drugs have proven so popular that the market value of the Danish company behind them recently exceeded the entire economy of Denmark

We will be comparing these two against one another, but before we do, there is one thing we have to take note of: There are not a lot of studies comparing one against the other